It is imperative individuals with cardiovascular diseases remain active despite COVID-19 lockdowns, said Antonio Pelliccia, MD, senior consultant and chief of cardiology at the Institute of Sports Medicine and Science, of the Italian National Olympic Committee.
It is imperative individuals with cardiovascular diseases remain active despite COVID-19 lockdowns, said Antonio Pelliccia, MD, senior consultant and chief of cardiology at the Institute of Sports Medicine and Science, of the Italian National Olympic Committee.
Transcript:
The American Journal of Managed Care® (AJMC®): What events prompted the need for updated guidelines on sports and exercise in patients with cardiovascular disease (CVD)?
Dr. Pelliccia: Well actually, the European Society of Cardiology was prompted to write these guidelines because of requests by the cardiologists. Obviously cardiologists know that exercise and eventually sport is very useful in control of several cardiovascular diseases. But when they are in front of the patient, and they are going to advise a sport...they are in doubt as to what kind of sport and what kind of intensity they should advise. The aim of this document is to teach the clinical cardiologists how to evaluate the patient with cardiovascular disease before advising exercise and sport participation.
One of the major objectives of this document is to improve the knowledge, in terms of the pathophysiology of exercise, as part of the overall cardiologist's [strategy] and make the cardiologist a very efficient category in order to promote exercise and sport participation. So, add the cardiologist to the sport physicians and the other physicians that actually are dealing with exercise and sports in order to provide, particularly patients with cardiovascular disease, the option to participate in exercise and sport in a safe manner without particular risk.
AJMC®: In the era of coronavirus disease 2019 (COVID-19), what are some tips you can offer to individuals with CVD to help them stay active?
Dr. Pelliccia: Well, this is very challenging. This is really very challenging. We are still experiencing these terrible lockdowns with people refraining from participating in the usual lifestyle sports. The idea that the patient with cardiovascular disease should remain active is even more important than for normal people. It's important for everyone, but it's still even more important for people with cardiovascular disease. So this is the option for people that have been not so far engaged in any sport at all, just to start out directly with this. For instance, jogging or walking, or running, according to the situation, according to the status of cardiac disease. But also there are some other activities such as golfing or maybe cycling. So all the outdoor activities that are related to a relatively lower risk for infection of COVID-19; it can be self management.
Before doing this, before engaging in sports, consultation and advice from a physician is always a very safe suggestion, particularly for those people that have been sedentary for life, and they have relatively scarce knowledge about their disease and how to manage their disease. Those people may benefit the most from a consultation with their physician and particularly cardiologists. And we have put that in this document, cardiologists but also the patients themselves [ought to] approach sports activity in a safe manner.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More